Presentation is loading. Please wait.

Presentation is loading. Please wait.

Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion.

Similar presentations


Presentation on theme: "Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion."— Presentation transcript:

1 Decontamination : Who, why, when and how

2 Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion What type of decontamination should be used? Depends on clinical circumstances and other treatment options

3 Decontamination w Syrup of Ipecac w Gastric lavage w Activated charcoal multi dose with cathartic w Whole bowel irrigation

4 Where is the Evidence ? Based on w Animal studies w Volunteer studies w clinical studies Difficulty due to w serious ingestions excluded w conflicting results

5 Where is the Evidence Position statements released in 1997 by AACT and EAPCCT “Overall the mortality from acute poisoning is less than 1 % and the challenge for clinicians is to identify promptly those who are at most risk of developing serious complications and who might potentially benefit, therefore, from gastrointestinal decontamination.”

6 Syrup of Ipecac w Plant extract previously abused by bullimics w needs to be given EARLY w induces vomiting by gastric and central mechanism Contraindicated in w unprotected airway w corrosive w very little evidence for or against w possible role in the home for children

7 Gastric lavage w No studies demonstate efficacy even < 60 min.s w Studies exclude serious poisonings Contraindicated: w dodgy airway reflexes w corrosives w hydrocarbon

8 Gastric lavage w May increase risk of aspiration w May lead to pharyngeal injury w alleged to increase absorption in some cases w Has lead to significant return of ingestants up to 12 hours post ingestion(salicylates) Indication w Serious life threatening poisoning with well protected airway (level IV evidence)

9 Activated charcoal w Will adsorb many toxins in GI tract BUT: Alcohols Li +, Fe 2+ (probably all alkali metals) w Ratio should be 10:1 AC:toxin w Evidence from volunteer studies that absorption will be  if < 60 min.s w Little to suggest benefits outcome clinically or absorption post 60 min.s DO NOT GIVE ROUTINELY

10 Activated charcoal w Beware the unprotected airway or aspiration risk w dose is 50g adult, 1g/kg in a child Cathartics w Alleged to increase bowel transit time of toxin w Evidence only from animal and volunteer studies w Unlikely to benefit

11 Multi dose activated charcoal w Works by GI dialysis drugs with significant enterohepatic circulation w examples: theophylline anticonvulsants salicylates digoxin

12 Multi dose activated charcoal w Good, though indirect evidence of effect in digoxin poisoning w 50g q 6 hrly OR by NG infusion if intubated w up to 1g/kg suggested for serious theophylline poisonings w Justifies “late” instigation of charcoal

13 Whole bowel irrigation Used for w SR/EC preparations w when charcoal is ineffective w No controlled clinical studies to back up use physically speeds up transit through GI tract single dose charcoal given prior to starting

14 Whole bowel irrigation w PEG ELS (“go-lytely”) is used  does not cause significant water/electrolyte disturbance w frequently causes vomiting, requires NGT w airway must be protected w ileus is CI but has been reversed with neostigmine w dose is 15-20 mls/kg/hr w endpoint is clear rectal effluent, median time to achieve this is 6 hours

15 A 50 kg female presents having ingested 6 g of paracetamol 5 hours previously

16 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

17 A 70 kg male presents having ingested 14 g paracetamol 3 hours before

18 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

19 A 70 kg male presents having ingested 14 g paracetamol 1 hour before

20 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

21 A 45 kg female presents having ingested 2 g of a tricyclic antidepressant 1 hour before

22 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

23 A 50 kg male presents unconscious having ingested an unknown amount of a tricyclic antidepressant at an unknown time

24 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

25 A 67 kg male presents having ingested 800 mg of a tricyclic antidepressant 6 hours before. He is well.

26 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

27 A 80 kg male presents having ingested 100 mg of diazepam 4 hours before

28 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

29 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

30 A 65 kg female presents having ingested 3.5 g of Verapamil SR 4 hours before.

31 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None

32 A 45 kg female presents having ingested 2 g elemental iron 4 hours before. Tablets are noted on her plain AXR

33 Would You w Syrup of Ipecac w Gastric lavage w Gastric Lavage & AC w Gastric lavage & Whole bowel lavage w AC w Whole Bowel Lavage w None


Download ppt "Decontamination : Who, why, when and how. Decontamination When should patient be decontaminated? risk of morbidity and/or mortality associated with ingestion."

Similar presentations


Ads by Google